YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

Distribution of Blood and Blood Components, Indications and Early Complications of Transfusion

dc.authorscopusid 36675032600
dc.authorscopusid 8518945300
dc.authorscopusid 55891957000
dc.contributor.author Efe, S.
dc.contributor.author Demir, C.
dc.contributor.author Dilek, I.
dc.date.accessioned 2025-05-10T17:06:56Z
dc.date.available 2025-05-10T17:06:56Z
dc.date.issued 2010
dc.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
dc.department-temp Efe S., Yuzuncu Yil University, Medical Faculty, Department of Internal Medicine, Division of Hematology 65200 Van, Turkey; Demir C., Yuzuncu Yil University, Medical Faculty, Department of Internal Medicine, Division of Hematology 65200 Van, Turkey; Dilek I., Yuzuncu Yil University, Medical Faculty, Department of Internal Medicine, Division of Hematology 65200 Van, Turkey en_US
dc.description.abstract Aim: It is aimed in this study to determine blood and blood component's transfusion indications, component using rate, early transfusion complications and the distribution of complications according to the blood component. Method: In this study, recipient's name, surname, age, gender, blood component, the clinic where transfusion have done, transfusion indications, whether or not transfusion history and complication, the amount and type of blood component, product waiting period in the blood center, vital findings before and after transfusion. Result: Percentage of transfused products was as follows: whole blood (50%), erytrocyte suspension (26%), fresh frozen plasma (19.8%) and platelet suspension (4.2%). Utilization rate of blood and blood components by service type was as follows: 30.8% in internal medicine, 11.9% in general surgery, 16.8% in obstetrics and gynecology, 15.3% in department of child health and disease and 25.2% in other service. Acute complication was observed in 3% of patients. 1.8% of them was developed acute febrile nonhemolytic transfusion reaction. Urticaria was observed in 0.95% of cases. Hypocalsemia in 2 patients (0.1%), hypotension in 2 patients (0.1%) using ACE inhibitory, hypertension in one patients (0.05%) and hypercalsemia in one patient (0.05%) after transfusion were observed in patients. Conclusion: Full blood utilization rates are high but it's close to Turkey average. Transfusion-related acute reaction rates were similar literature rates. It has suggested that information work should be increased to increase the use of component and to protect patients from unnecessary risk. en_US
dc.identifier.doi 10.29333/ejgm/82841
dc.identifier.endpage 149 en_US
dc.identifier.issn 1304-3889
dc.identifier.issue 2 en_US
dc.identifier.scopus 2-s2.0-78650109076
dc.identifier.scopusquality N/A
dc.identifier.startpage 143 en_US
dc.identifier.uri https://doi.org/10.29333/ejgm/82841
dc.identifier.uri https://hdl.handle.net/20.500.14720/6604
dc.identifier.volume 7 en_US
dc.identifier.wosquality N/A
dc.language.iso en en_US
dc.publisher TIP ARASTIRMALARI DERNEGI en_US
dc.relation.ispartof European Journal of General Medicine en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.subject Blood en_US
dc.subject Component en_US
dc.subject Early Complication en_US
dc.subject Indication en_US
dc.subject Transfusion en_US
dc.title Distribution of Blood and Blood Components, Indications and Early Complications of Transfusion en_US
dc.type Article en_US

Files